Status:
RECRUITING
Temporal Interference Brain Stimulation Phase I Clinical Trial
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Health Adults
Temporal Interference Stimulation
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
The goal of this clinical trial is to validate if temporal interference brain stimulation (TIBS) is safe in healthy volunteers aged 20 to 65. The main questions it aims to answer are: * Is it safe to...
Eligibility Criteria
Inclusion
- Healthy adults from the community
- Age between 20 and 65 years old
- No diagnosis of severe psychiatric disorders
- No family history of psychiatric diseases
Exclusion
- Age below 20 years old or above 65 years old
- Currently prescribed any medication
- Diagnosis of psychiatric disorders (e.g., Major Depressive Disorder, Bipolar Disorder, Schizophrenia)
- Diagnosis of neurological disorders (e.g., Dementia, Stroke, Parkinson's disease)
- History of substance abuse
- Diagnosis of cancer or malignant tumors
- Chronic kidney failure or undergoing hemodialysis
- Pregnant or breastfeeding
- Severe arrythmia, presence of pacemaker, or metal implants in the brain
- Claustrophobia
- History or family history of seizure
- History of syncope
- Organic brian disease, brain trauma, or history of neurosurgery
- Received electroconvulsive therapy or repetitive transcranial magnetic stimulation within the past month
- Skin disoreders (e.g., dermatitis, psoriasis, eczema)
- Currently participating in other clinical interventional trials
- Presence of any metal implants or devices affected by electromagnetic fields
Key Trial Info
Start Date :
February 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07179848
Start Date
February 26 2025
End Date
October 1 2025
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, 112